LDH (IFCC)
Lactate dehydrogenase (LDH) - tumor marker · class III · Until 05/10/2036
- Registration no.
- 80254180494
- Process no.
- 25351139958202688
- Status
- Until 05/10/2036
- Device type
- Lactate dehydrogenase (LDH) - tumor marker (LACTATO DESIDROGENASE (LDH) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER)
- Risk class
- III
- Registration holder
- PHADIA DIAGNOSTICOS LTDA CNPJ 04.930.429/0001-39 · 497 registrations
- Manufacturer
- Published
- 05/10/2026
- Valid until
- 05/10/2036
- Last updated by ANVISA
- 2026-10-12
- Official record
- View on ANVISA ↗
Other lactate dehydrogenase (ldh) - tumor marker registrations (4 in total, see all)
| Product | Class | Holder | Published | Status |
|---|---|---|---|---|
| Família Lactate Dehydrogenase acc. to IFCC ver.2
10287411812 |
III | ROCHE DIAGNÓSTICA BRASIL LTDA | 21/09/2026 | Until 21/09/2036 |
| Lactate Dehydrogenase2 (LDH2)
80146502431 |
III | ABBOTT LABORATORIOS DO BRASIL LTDA | 27/07/2026 | Until 27/07/2036 |
| Alinity c Lactate Dehydrogenase2 (LDH2)
80146502432 |
III | ABBOTT LABORATORIOS DO BRASIL LTDA | 27/07/2026 | Until 27/07/2036 |